1. Epigenetic Regulation of Werner Syndrome Gene in Age-Related Cataract
   Xi Zhu et al, 2015, Journal of Ophthalmology CrossRef
2. Molecular Pathology of Cervical Dysplasia and Carcinoma
   Yimin Ge et al, 2017, Precision Molecular Pathology of Uterine Cancer CrossRef
3. Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer
   Samatha Bhat et al, 2016, Biochimie CrossRef
4. Role of DNA Methylation in the Resistance to Therapy in Solid Tumors
   Susana Romero-Garcia et al, 2020, Frontiers in Oncology CrossRef
5. Werner syndrome: association of premature aging and cancer predisposition
   Byungchan Ahn et al, 2013, Molecular Oncology CrossRef
6. RecQ Helicase Somatic Alterations in Cancer
   Megha K. Thakkar et al, 2022, Frontiers in Molecular Biosciences CrossRef
7. Insights into therapy resistance in cervical cancer
   Irene A. George et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
8. Pharmacoepigenomics and Pharmacovigilance in Gynecological Cancers
   Ang Sun, 2016, Gynecological Cancers CrossRef
9. RETRACTED ARTICLE: WRN inhibits oxidative stress-induced apoptosis of human lensepithelial cells through ATM/p53 signaling pathway and its expression is downregulated by DNA methylation
   Shengqun Jiang et al, 2020, Molecular Medicine CrossRef
10. Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors
    Moustafa M. Madkour et al, 2023, Annals of Medicine CrossRef
11. Epigenetic Modifications in Breast Cancer and Their Role in Personalized Medicine
    Olafur A. Stefansson et al, 2013, The American Journal of Pathology CrossRef
12. Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review)
    MIHO IIDA et al, 2014, Molecular and Clinical Oncology CrossRef
13. Mechanisms of chemotherapy resistance in cervical cancer
    Rahaba Marima et al, 2024, Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer CrossRef
14. A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan
    Valerie Lee et al, 2018, Clinical Cancer Research CrossRef
15. Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer
    Yongjun Cha et al, 2019, Neoplasia CrossRef
16. Discovering New Medicines Targeting Helicases: Challenges and Recent Progress
    William R. Shadrick et al, 2013, SLAS Discovery CrossRef
17. WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy
    Linda J.W. Bosch et al, 2016, Clinical Cancer Research CrossRef
18. Effects of shRNA‐mediated silencing of PSMA7 on cell proliferation and vascular endothelial growth factor expression via the ubiquitin‐proteasome pathway in cervical cancer
    Chen‐Chen Ren et al, 2019, Journal of Cellular Physiology CrossRef
19. KLF5 promotes cervical cancer proliferation, migration and invasion in a manner partly dependent on TNFRSF11a expression
    Dong Ma et al, 2017, Scientific Reports CrossRef
20. Promoter Hypermethylation of KLF4 Inactivates Its Tumor Suppressor Function in Cervical Carcinogenesis
    Wen-Ting Yang et al, 2014, PLoS ONE CrossRef
21. Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update
    Pere Llinàs-Arias et al, 2017, Open Biology CrossRef
22. A case of Bloom syndrome manifesting with therapy-related myelodysplastic syndromes harboring a novel BLM gene variant
    Takuma Ohashi et al, 2024, International Journal of Hematology CrossRef